Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Beta Therapeutics divulges new heparanase inhibitors

July 13, 2018

GlaxoSmithKline, Astex Therapeutics describe NRF2 activators

July 13, 2018

Galapagos, AbbVie discover CFTR modulators

July 12, 2018

National Center for Global Health and Medicine, Kumamoto University and Yamasa patent antivirals

July 12, 2018

Amgen describes new beta-secretase inhibitors

July 12, 2018

Hitgen describes Rho-associated protein kinase inhibitors

July 11, 2018

Dihydroceramide desaturase inhibitors presented by Centaurus Therapeutics

July 11, 2018

Janssen Pharmaceutica discovers new menin/MLL interaction inhibitors

July 11, 2018

Aurigene Discovery Technologies patents BRD4 inhibitors

July 11, 2018

New NFE2L2 activators identified at GlaxoSmithKline

July 11, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...